Chapter 13: Anesthetics

0:00 / 0:00
Report an issue

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace, the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, usually when you think about taking a medication, you sort of expect a simple on and off switch.

You have a headache.

You swallow a pill.

The headache vanishes.

Oh, it's binary.

Yeah, exactly.

It's clean.

It makes sense.

But the moment you step into the world of anesthesiology, that simple on off switch just completely shatters.

It really does.

It's way more complex.

You're suddenly looking at a landscape that is far more like a highly sensitive multi -channel dimmer switch on a theater light board.

I mean, you're literally hijacking the human nervous system.

And spoiler alert, we don't even really know where the master off switch actually is.

No, we really don't.

It is the ultimate exercise in controlled physiological chaos.

I mean, you're bringing a patient to the very brink of death, holding them there safely while someone operates and then bringing them back.

All just by carefully turning those dimmer dials.

Exactly.

So, today on The Deep Dive, we are tearing into the wild pharmacology of anesthetics.

And we're custom tailoring this session specifically for you, the college student who's staring down pharmacology for the very first time.

Your official last minute lecture prep session.

You got it.

We are going to unpack the foundational physiology, the specific drug targets,

and the clinical realities found in your textbook's chapter on anesthetics, Lippincott Chapter 13, to be exact.

And you know, the core problem we have to solve right out of the gate is that there is absolutely no magic bullet in anesthesia.

None at all.

None.

If you look at the foundational data charting drug effects in the text, it becomes incredibly clear.

Like, no single pill or gas can magically provide sedation, memory wipe, muscle relaxation, and pain relief all at once.

Without, you know, killing the patient.

Right.

Without killing the patient.

Achieving that state requires a highly choreographed recipe of multiple drug classes.

You are moving a patient down a continuum.

Like the dimmer switch.

Exactly.

From minimal sedation, where they just feel relaxed and can answer your questions, down through moderate and deep sedation all the way to general anesthesia.

And the textbook draws a massive line in the sand at general anesthesia.

Because I mean, this isn't just a really deep sleep.

No, not at all.

At this level, the patient is completely unarousable, even to severe pain.

And their body has actually lost the ability to keep them breathing.

Medical intervention is mandatory to maintain their airway there.

So the immediate clinical problem becomes, once we have them down at that profound depth, how do we keep them there safely for a, you know, a three hour surgery?

Well, we usually rely on continuous inhaled gases for that.

But before we introduce the specific gases, we really have to understand how to measure their pharmacological power.

Because you can't just weigh a gas on a scale.

Exactly.

The measurement has to be functional.

So the concept you absolutely must master here is MS.

That stands for Minimum Alveolar Concentration.

MS.

Right.

And the data defines MS quantitatively as the specific percentage of a gas in a mixture needed to stop 50 % of patients from physically moving in response to a painful stimulus.

Like a surgical incision.

Exactly.

Like a scalpel cut.

Let me stop you there, though, because the math on M .A .C.

is completely backwards from what intuition tells you.

It really is.

It's a strictly inverse relationship, right?

A high MAC number means the drug is actually incredibly weak.

That inverse relationship catches people off guard constantly.

Take nitrous oxide, which most people know as laughing gas.

It's M .A .C.

is a staggering 105%.

Wait, 105 %?

So which means theoretically, to get half of your patients to start moving using only nitrous oxide, you'd have to give them a gas mixture that is over 100 % nitrous oxide.

Which is physically impossible unless you completely remove all the oxygen from the room.

Which obviously suffocates your patient.

Right.

You can't do that.

So nitrous oxide alone is far too weak to ever produce surgical general anesthesia.

Got it.

Now compare that to a drug like isoflurane.

Its M .A .C.

is tiny.

Just 1 .2%.

Wow.

That's a huge difference.

Yeah.

A minuscule fraction of gas mixed with oxygen gets the job done because isoflurane is highly potent.

But those M .A .C.

numbers, they can't be universal constants, right?

Right.

Like a 20 -year -old athlete and an 80 -year -old grandmother surely don't have the exact same sensitivity to a drug.

They absolutely don't.

And the textbook lists specific physiological states that shift a patient's M .A .C.

Like what?

Well, if a patient has hyperthermia, so a high fever, or a history of chronic alcohol abuse, their central nervous system is essentially hyperstimulated or deeply adapted to depressants.

Okay.

So they become resistant.

Exactly.

Their M .A .C.

increases, meaning you have to pump in significantly more gas to keep them under.

And on the flip side, what decreases M .A .C., what makes them more offensive?

Things that make the patient much more fragile.

So older age, hypothermia, pregnancy, or if they are already flooded with other A .V.

sedatives, they need drastically less gas.

So that's the potency.

Yeah.

But having a highly potent gas with a great M .A .C.

value is entirely useless if the drug is just, you know, sitting in the patient's lungs.

Right.

The plumbing of the operation, the pharmacokinetics, dictates how we get that gas from the alveoli in the lungs, dissolved into the blood, and finally pushed across the blood -brain barrier to actually shut down consciousness.

And this all comes down to a property called the blood -gas partition coefficient, which is basically solubility.

Exactly.

Solubility.

Let me try an analogy to visualize this.

Imagine the patient's bloodstream is a massive sponge.

Yeah.

Right?

And this sponge is a pharmacologically inactive reservoir because drug trapped in the blood isn't doing anything to the brain.

That's a great way to look at it.

So if an anesthetic gas has very low blood solubility, like nitrous oxide, it means the blood sponge doesn't want to hold on to it.

The sponge saturates almost instantly.

And because that sponge can't hold any more of the gas, every new breath the patient takes forces the gas to immediately overflow straight out of the blood and into the brain.

That's fast.

Incredibly fast.

Because the blood refuses to soak it up, you get a lightning -fast induction of anesthesia.

The patient goes under quickly.

Conversely, if a gas have a high blood solubility, like isoflurane, that blood sponge acts like a bottomless pit.

It just keeps soaking up molecule after molecule.

Yeah.

Pulling massive amounts of the gas into the bloodstream before any meaningful concentration ever builds up enough to spill over into the brain.

So induction is painfully slow.

Yeah.

The solubility in the blood directly dictates the speed of the drug.

Isoflurane is highly soluble, so it's sluggish.

Dust fluorine and nitrous oxide are poorly soluble, so they are incredibly fast.

Wait.

I have to challenge something right out of the text here.

Because the cardiac output data feels completely paradoxical.

The cardiac output, yeah.

The chapter states that a lower cardiac output, meaning a slower, weaker heartbeat, actually causes a faster induction time for these inhaled gases.

But I mean, basic plumbing says a faster pump should deliver the drug to the brain quicker, shouldn't it?

It feels backwards, totally, until you look at the transit time in the pulmonary circulation.

Picture the blood moving through the tiny capillaries in the lungs.

When a patient has a low cardiac output, that blood is creeping along.

It's moving really slowly.

Yeah.

It sits in the lungs for a prolonged period.

So it's basically lingering at the loading dock.

Precisely.

Because it sits there so long, a massive, highly concentrated bolus of the anesthetic gas has time to cross over and dissolve into that specific volume of blood.

Okay, I'm following.

Then, when that incredibly dense, heavily loaded bolus eventually makes its way to the brain, it is moving slowly past the blood -brain barrier, too.

That extended contact time allows massive amounts of the drug to diffuse into the brain tissue all at once, knocking the patient out quickly.

Ah, I see.

So a fast, racing heart would rush the blood past the lungs so quickly it could only grab a tiny sprinkle of the gas, and then it would whip past the brain before it could effectively drop that gas off.

Exactly.

A high cardiac output spreads the drug out too thin, sabotaging your induction speed.

That makes so much sense now.

And when the surgery is over and you want the patient to wake up, the washout process is just this exact physiological mechanism operating in reverse.

Got it.

A highly insoluble gas like nitrous oxide abandons the blood and exits through the lungs rapidly, while isoflurane slowly leeches out of that blood spud for a long time.

You've got it.

Okay, so we've solved the plumbing.

The gas is in the brain.

What are these halogenated hydrocarbon molecules actually doing to the neurons?

Well, for most of these volatile gases, the primary mechanism of action involves potentiating GABA receptors.

And GABA is the brain's main inhibitory neurotransmitter.

Right.

When the anesthetic binds,

it forces chloride channels on the neuron to open wider and stay open longer.

Negative chloride ions flood into the cell, hyperpolarizing it.

You're basically drowning out the electrical noise and forcing the brain to quiet down.

But nitrous oxide doesn't play by the GABA rules.

No, it doesn't.

Nitrous oxide, along with the IV drug ketamine, ignores GABA entirely.

Instead, they block NMDA receptors.

NMDA receptors.

Yeah, NMDA is the receptor for glutamate, which is the central nervous system's main excitatory neurotransmitter.

So instead of slamming on the chemical brakes like the other gases,

nitrous oxide just cuts the accelerator cable integrally.

Exactly.

So let's apply these gases to actual clinical problems.

Say you have long routine surgery.

You might reach for isofluring.

You might.

The text notes it's cheap and effective, but it is incredibly pungent.

Look, it smells bad.

Very bad.

It smells harsh and severely irritates the airway.

Plus, because of that high solubility we talked about, it takes forever to reach equilibrium.

Any other side effects?

Yeah.

It also causes dose -dependent hypertension, meaning their blood pressure will drop the more you give.

Which is why you wouldn't use isofluring for a quick 15 -minute outpatient procedure.

Definitely not.

For that, you need desflurane.

Because of its extremely low solubility, desflurane offers very rapid onset and very rapid recovery.

But there's a catch with desflurane.

Right, a big one.

It's so volatile at room temperature that it requires a specialized heated vaporizer on the anesthesia machine just to deliver it safely.

And like isoflurane, it severely burns the airway.

Ouch.

Yeah, if you put a mask of desflurane on an awake patient, their airway would spasm violently.

Which brings up a huge clinical dilemma.

What if your patient is a terrified five -year -old child who absolutely refuses to let you put an IV in their arm?

You can't use an irritating gas.

That is where seboflurane shines.

It is the sweet smelling option.

Oh, nice.

Yeah, it has very low pungency, meaning it does not irritate the respiratory tract at all.

You can literally just have the pediatric patient breathe the sweet gas through a mask and they will drift off to sleep smoothly, allowing you to place the IV after they're unconscious.

But the textbook has a glaring warning box regarding seboflurane.

Yes, it does.

It can form highly nephrotoxic compounds, meaning it literally destroys the patient's kidneys.

Right.

And this happens if the drug reacts with the soda lime, which is the chemical used in the anesthesia machine's breathing circuit to absorb carbon dioxide.

So how does that happen?

If the anesthesiologist sets the fresh gas flow too low, the seboflurane sits in that soda lime too long, cooks into a toxic byproduct, and damages the kidneys.

Wow, a vital clinical pro right there.

You have to keep the gas flowing to prevent that chemical reaction.

Absolutely.

Finally, we have nitrous oxide.

As we establish, it is too weak for general anesthesia, but it is phenomenal for moderate sedation, particularly in dentistry.

Right, laughing gas.

Yeah.

It provides fantastic pain relief without depressing the patient's breathing or dropping their blood pressure.

But its exit strategy is pretty violent.

The textbook highlights a phenomenon called diffusion hypoxia.

Yes.

Because nitrous oxide is so incredibly insoluble in blood, the moment the dentist turns off the gas,

all of that nitrous oxide violently rushes out of the bloodstream and dumps into the lungs.

It floods the alveoli so fast and in such massive volumes that it physically displaces and crowds out the normal room air.

Exactly.

The patient can actually suffocate and become hypoxic simply from breathing out the drug.

That's terrifying.

So how do you stop that?

To prevent that, you must administer a high concentration of pure 100 % oxygen during the recovery phase to flush the nitrous oxide out of their lungs safely.

Good to know.

Now, before we move away from inhaled gases entirely, we have to talk about the absolute nightmare scenario in anesthesiology.

It's a classic exam question.

Malignant hyperthermia.

It is a terrifying, life -threatening emergency.

In a small subset of the population with a specific genetic mutation, exposure to any of these halogenated gases or exposure to a paralyzing drug called succinylcholine triggers a catastrophic cellular malfunction.

The gas essentially causes the sarcoplasmic reticulum inside their muscle cells to malfunction.

And for context for you listening, the sarcoplasmic reticulum is basically the storage vault for calcium inside a muscle.

When calcium is released, the muscle contracts.

And in malignant hyperthermia, the doors to that vault get blown wide open.

Massive, uncontrollable amounts of calcium flood the muscle cells.

The muscles contract violently and continuously.

This hypermetabolic state generates extreme heat, causing the patient's core temperature to skyrocket.

They develop severe muscle rigidity and their circulatory system rapidly collapses.

Their muscles are essentially cooking them from the inside out, just from breathing a routine gas.

Exactly.

If a patient starts boiling on the table, the text is extremely clear on the sole life -saving antidote.

You must immediately push a drug called dantrolene.

Dantrolene, yes.

It works by physically blocking the release of calcium from that sarcoplasmic reticulum, slamming the vault doors shut, and halting the muscular melt -out.

It is literally the only way to save their life in that scenario.

Okay, so we've covered the gases that maintain a deep sleep, but we also noted that breathing in most of these gases is irritating and agonizingly slow for an adult.

We don't want an adult patient gagging on a mask for 10 minutes.

We want a 60 -second knockout.

Right, and we achieved that using intravenous anesthetics.

Pushing a drug directly into the vein bypasses the lungs entirely, allowing us to induce unconsciousness in just 30 to 40 seconds.

But looking at the pharmacokinetic data for these IV drugs reveals a massive physiological paradox.

Let's look at a classic barbichirate called Cypentol.

Okay, thiopentol.

A patient receives a single IV push.

They fall asleep in seconds, but then they wake up just a few minutes later.

The catch?

The liver requires hours to actually metabolize and break down that barbichirate molecule.

Right.

So if the drug hasn't been destroyed by the liver yet, why did the patient wake up?

That paradox is explained by the concept of redistribution.

Redistribution, yeah.

When you push an IV drug, it travels directly in the blood to the organs that receive the highest volume of blood flow.

We call this the vessel -rich group, which primarily includes the brain, the heart, and the kidneys.

So the massive wave of drug slams into the highly perfused brain, and boom, the patient is unconscious.

But the drug doesn't stay locked in the brain.

Because these anesthetics are highly lipid soluble, they easily cross membranes.

As the blood continues to circulate, it starts delivering the drug to larger, high -capacity storage compartments that get less initial blood flow.

Like what?

Specifically, the massive beds of skeletal muscle and fat tissue.

As the drug seeps into the fat, the concentration in the blood drops, which pulls the drug back out of the brain to balance things out.

Wow.

Okay, so the patient regains consciousness simply because the drug relocated from their brain into their fat cells.

Exactly.

It wasn't destroyed, it just moved out of the control room.

That's a great way to put it.

Let's look at how we solve clinical problems with this specific IV lineup.

The undisputed king of induction is propofol.

It is fast, but it has one massive therapeutic superpower that sets it apart from almost everything else.

Yeah, propofol is uniquely anti -medic.

It actively suppresses post -operative nausea and vomiting.

Which is huge.

Right.

Given how deeply nauseating surgery and opioids can be, having an induction agent that simultaneously settles the stomach makes it the gold standard for most routine surgeries.

But propofol causes a profound drop in blood pressure.

What if you have a trauma patient rolling into the ER who has lost a massive amount of blood and their pressure is already dangerously low?

Propofol would stop their heart.

Yes, it would.

In that scenario, we use automidate.

Automidate is incredibly cardiovascular stable.

It puts the brain to sleep without crashing the blood pressure.

But it harbors a fatal flaw if you use it for anything more than a quick induction.

It does.

If you run a continuous infusion of automidate, it aggressively inhibits an enzyme called 11 -beta -hydroxylase.

What does that do?

That enzyme is an absolute requirement for steroidogenesis in the adrenal glands.

By blocking it, automidate completely shuts down the patient's ability to synthesize cortisol and aldosterone.

And cortisol is your body's primary stress hormone.

I mean, having your body sliced open by a surgeon is the ultimate physical stress.

If you cannot produce cortisol to manage that stress, you will go into irreversible shock.

Exactly.

So automidate is strictly a quick one -and -done injection.

Now what if the patient is not only bleeding out on hypovolemic shock, but they also have severe asthma?

You need an anesthetic that supports blood pressure and keeps the airways open.

That calls for ketamine.

Ketamine is wild.

As we mentioned earlier, it blocks those excitatory NMDA receptors, which creates a dissociative state.

The patient might literally have their eyes open looking around the room, but they are completely disconnected from their environment and feeling profound analgesia.

And the unique trick of ketamine is that it acts as a sympathetic nervous system stimulant.

While almost every other anesthetic depresses the body, ketamine causes a surge of catecholamines.

Yeah, it drives the heart rate up, spikes the blood pressure, and is a highly potent bronchodilator throwing the airways wide open.

It is a lifesaver for asthmatics in shock.

But there's a trade -off, right?

Its psychological profile.

A huge trade -off.

Because it is a chemical derivative of PCP, waking up from ketamine can be a terrifying psychological trip.

Patients frequently experience emergence delirium, vivid, horrifying hallucinations, and out -of -body nightmares.

Yikes.

So how do you manage that?

To blunt that trauma, anesthesiologists will often pre -treat the patient with a benzodiazepine to calm the brain down before the ketamine wears off.

Makes sense.

Rounding out our five E options, we have dexmitetomidine.

Dexmitetomidine, right.

This is an alpha -2 adrenergic agonist.

It works on specific receptors in the brainstem to provide a very natural feeling sedation and pain relief without depressing the respiratory drive.

Which is incredibly useful.

The patient can actually be roused to follow commands and then drift right back to sleep, making it exceptionally useful in intensive care units and for calming severe emergence delirium in pediatric patients.

So we have handled the brain.

The patient is unconscious and stable.

But the surgeon is complaining because every time they touch the scalpel to the patient, the skeletal muscles reflexively twitch.

They need the body perfectly still to make precise cuts.

Plus, we need to manage the localized nerve pain of the incision itself.

To stop the twitching, we administer neuromuscular blockers, paralytic drugs like rocoronium or vecuronium.

These drugs travel to the neuromuscular junction and physically block the nicotinic acetyl toluene receptors on the muscle membrane.

So the nerve keeps shouting at the muscle to move, but the receptor is plugged, so the muscle stays completely flaccid.

Exactly.

But when the surgery ends, you need the patient to breathe on their own again, which means you have to undo that paralysis fast.

The text highlights a fascinating reversal agent called Sugamadex.

Oh, Sugamadex is amazing!

This isn't just a drug that competes for a receptor,

Sugamadex is a precisely engineered three -dimensional molecular cage.

Yeah, literally a cage.

It floats into the bloodstream, physically envelops the rocuronium molecule, and traps it in a perfect one -to -one ratio.

It literally kidnaps a paralytic away from the muscle, instantly reversing the paralysis.

Wow, that is a stunning piece of targeted chemical engineering.

Isn't it?

Meanwhile, to handle the localized pain of the scalpel cuts, we use local anesthetics.

Whether it is a lidocaine injection at the dentist or an epidural, these drugs function by blocking sodium channels on the targeted nerve membrane.

If sodium cannot rush into the nerve cell, the nerve cannot generate an electrical action potential.

If there is no electrical spark, the pain signal simply never travels from the surgical site up the spinal cord to the brain.

The pain is literally stopped in its tracks.

Exactly.

But this brings up a classic patient observation.

People constantly claim they are allergic to local anesthetics.

They go to the dentist, get a shot of novocaine, their heart starts pounding out of their chest, and they tell everyone they have a severe local anesthetic allergy.

And the textbook actually dismantles this beautifully.

It absolutely does, by dividing local anesthetics into two distinct structural families – Alides and Esters.

And the text provides a really simple spelling trick to tell them apart.

Oh, the spelling trick, yes.

Drugs with two I's in their generic name,

like LIDOCAINE or UPIVACAINE,

are amides.

Amides are metabolized cleanly by the liver.

True immunological allergic reactions to amide anesthetics are exceedingly, almost vanishingly rare.

On the other hand, drugs with only one I in their name, like tetrakane or procane, are esters.

Esters are not broken down in the liver.

They are metabolized right in the bloodstream by plasma cholinesterase enzymes, and they break down into a byproduct called PAVA, or paraminobinzoic acid.

And PAVA is a known, highly reactive allergen.

Right.

If a patient has a genuine allergic reaction, like hives, airway swelling, it is almost certainly to an ester.

So if true allergies to the common amides used at the dentist are so rare, why does the patient's heart race so violently after the injection?

It's not an allergy at all.

It is a direct physiological reaction to the epinephrine that is purposefully mixed into the syringe.

Wait, why are we injecting adrenaline into a dental patient's jaw?

Because epinephrine causes intense local vasoconstriction, it tightly shrinks the blood vessels right around the injection site.

By clamping those vessels shut, the epinephrine traps the numbing anesthetic in the local tissue for a much longer time, drastically increasing the duration of pain relief.

Wow, that's cool.

And importantly, it also prevents the anesthetic from washing away into the systemic blood circulation, where it could travel to the heart and brain and cause fatal toxicity.

So the racing heart the patient feels is just a brief harmless adrenaline rush from the epinephrine, not an allergy.

That makes perfect sense.

So to finally wrap up this surgical journey, we have to look at the bookends.

Because again, anesthesia is a complex recipe.

We bookend the heavy anesthetics with adjunct medications to prepare the body and manage the aftermath.

Right.

The textbook emphasizes multimodal analgesia here.

We want to avoid relying entirely on massive, heavy doses of opioids like fentanyl.

Because opioids are great for pain, but they cause severe respiratory depression, slow down the gut, and importantly, they offer zero amnesia properties.

A patient could be paralyzed, pain -free, but completely awake and forming memories of the surgery.

Exactly.

To spare the need for high -dose opioids, we attack the pain pathways from multiple different simultaneously using NSAIDs like silcoxib, standard acetaminophen, or GABA analogs like gabapentin.

On the front end, before they even see the surgical lights, we manage their sheer terror using benzodiazepines, specifically midazolam.

Midazolam heavily reduces anxiety, but its greatest feature is that it induces dense anterograde amnesia.

It essentially unplugs the brain's hard drive so the patient cannot form any new traumatic memories of being wheeled into the cold operating room.

And on the back end, as they are waking up in recovery, if the propofol wasn't quite enough to stop the post -operative nausea, we bring in targeted anti -medics like Ondansetron.

Yes, Ondansetron works by aggressively blocking 5 -HT3 receptors.

5 -HT3?

Yeah, 5 -HT3 is a specific subtype of serotonin receptor that acts as a trigger in both the gastrointestinal tract and the brain's vomiting center.

By blocking that specific serotonin signal, you shut down the reflex to vomit.

Wow, it is a breathtakingly complex, highly choreographed chemical dance from the moment they enter the hospital to the moment they leave.

But I want to leave you, the listener, with a final mind -bending reality check straight from the closing thoughts of this textbook chapter.

Despite all of this incredibly precise molecular science, despite knowing exactly how to tweak lipid solubility, how to trap paralytics in 3D molecular cages, and how to selectively block sodium channels, we still have absolutely no idea what the specific general anesthesia receptor actually is.

It is a humbling truth.

The text explicitly states that no single receptor has ever been identified.

Every single day, anesthesiologists use a cocktail of chemically unrelated compounds to hijack human consciousness, relying on observable data without a unified molecular theory.

We know exactly how to operate the dimmer switches.

We can manipulate the dials beautifully.

But the exact liberal master off switch for human consciousness, it really is a profound,

terrifying and beautiful mystery.

Something for you to ponder as you walk into your exam.

A phenomenal reminder that no matter how thick the textbook gets, there is always more to learn in pharmacology.

Absolutely.

Thank you for tuning in to this deep dive study session.

On behalf of the Last Minute Lecture Team, good luck and keep digging deeper.

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

Chapter SummaryWhat this audio overview covers
Anesthetic pharmacology encompasses a spectrum of agents and techniques designed to produce reversible central nervous system depression for surgical procedures and sedation. Anesthesia exists along a continuum of depth, progressing from minimal sedation in which patients remain responsive to verbal commands through moderate sedation to general anesthesia characterized by complete loss of consciousness and protective reflexes. General anesthesia itself unfolds through distinct phases: induction marks the rapid transition to unconsciousness, maintenance sustains the anesthetic state throughout the procedure, and recovery involves the gradual restoration of consciousness and protective airway reflexes, a process governed primarily by redistribution of the drug away from the central nervous system rather than hepatic metabolism. Inhalation agents serve primarily as maintenance medications and their potency is quantified using the minimum alveolar concentration metric, which represents the end-tidal concentration preventing movement in half of exposed patients during noxious stimulation. The kinetics of inhalation anesthetics depend critically on blood-gas solubility; agents with low solubility such as nitrous oxide and desflurane enable rapid induction and emergence, while highly soluble agents like isoflurane produce slower onset and recovery profiles. Most volatile anesthetics enhance the sensitivity of gamma-aminobutyric acid type A receptors to increase chloride conductance and neuronal hyperpolarization, though nitrous oxide operates distinctly through N-methyl-D-aspartate receptor antagonism. Intravenous induction agents including propofol, ketamine, etomidate, and dexmedetomidine each possess unique pharmacodynamic profiles suited to different clinical circumstances, from rapid sequence intubation to patients with compromised hemodynamic stability. Local anesthetics function by blocking sodium channel activity to prevent action potential propagation along nerve fibers; these agents are classified as amides metabolized hepatically or esters hydrolyzed by plasma cholinesterase, with their onset determined by acid-dissociation constant and their duration by lipid solubility. Adjunctive medications including neuromuscular blocking agents, antiemetics, and multimodal analgesic approaches optimize perioperative safety and patient comfort while minimizing adverse effects and total opioid exposure.

Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.

Support LML ♥